FLSM
SVRA icon

Frazier Life Sciences Management’s Savara SVRA Stock Holding History

Frazier Life Sciences Management’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.9M Hold
9,720,852
– – 1.3% 16
2026
Q1 		$53.1M Sell
9,720,852
-141,449
-1% -$787K 1.37% 17
2025
Q4 		$59.5M Sell
9,862,301
-1,600,000
-14% -$7.84M 1.6% 18
2025
Q3 		$40.9M Hold
11,462,301
– – 1.23% 20
2025
Q2 		$26.1M Hold
11,462,301
– – 1.05% 21
2025
Q1 		$31.8M Buy
11,462,301
+2,801,922
+32% +$7.74M 1.45% 17
2024
Q4 		$26.6M Buy
8,660,379
+502,994
+6% +$1.75M 1.1% 22
2024
Q3 		$34.6M Hold
8,157,385
– – 1.39% 22
2024
Q2 		$32.9M Buy
8,157,385
+4,157,385
+104% +$18.5M 1.54% 21
2024
Q1 		$19.9M Hold
4,000,000
– – 0.84% 32
2023
Q4 		$18.8M Hold
4,000,000
– – 1.01% 28
2023
Q3 		$15.1M Buy
+4,000,000
New +$14.3M 1% 23

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Frazier Life Sciences Management's SVRA Position: Q2 2026 in Review

Frazier Life Sciences Management held its Savara (SVRA) position steady in Q2 2026 at 9,720,852 shares worth $59.9M. The position accounts for 1.3% of the portfolio, ranked #16.

Frazier Life Sciences Management first reported a position in SVRA in Q3 2023 and has held it in 12 quarters since. 181 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • Frazier Life Sciences Management held 9,720,852 shares of Savara worth $59.9M as of Q2 2026.
  • Frazier Life Sciences Management left its Savara share count unchanged in Q2 2026.
  • Savara made up 1.3% of Frazier Life Sciences Management's portfolio in Q2 2026, its #16 holding.
  • Frazier Life Sciences Management first reported a position in Savara in Q3 2023 and has held it in 12 quarters since.
  • 181 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on Frazier Life Sciences Management's 13F filing for Q2 2026, filed 14 Aug 2026.